Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 256.00
+5.00 (1.99%)
Aug 27, 2026, 3:30 PM JST
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 4.18 billion as of August 26, 2026. Its market cap has increased by 10.09% in one year.
Market Cap
4.18B
Enterprise Value
4.58B
Revenue
13.64B
Ranking
n/a
PE Ratio
126.67
Stock Price
256.00
ChartMarket Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 4.18B, a decrease of -57.25%. That is a compound annual growth rate of -3.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 4.18B | -17.70% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PRISM BioLab Co.,LTD | 6.28B |
| Soiken Holdings | 5.89B |
| Cyfuse Biomedical K.K. | 5.55B |
| D. Western Therapeutics Institute | 5.12B |
| TMS Co., Ltd. | 5.02B |
| J-Pharma | 4.86B |
| Ribomic | 4.75B |
| Kohjin Bio | 4.32B |